Search results for pancreatic.
Found 8 clinical studies.
Official Title A Phase III Randomized Trial Of Dose Escalated Radiation In Locally Advanced Pancreas Cancer (Lapc) Patients (Lap100)
- Investigator: Jordan Kharofa
- Posted Date: Aug 11, 2025
- Type of Study: Drug
Rasolute 302: A Phase 3 Multicenter, Open-Label, Randomized Study Of Daraxonrasib (Rmc-6236) Versus Investigator's Choice Of Standard Of Care Therapy In Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (Pdac)
- Investigator: Davendra Sohal
- Posted Date: Apr 15, 2025
- Type of Study: Drug
A Study To Learn About The Study Medicine Pf-07934040 When Given Alone Or With Other Anti-Cancer Therapies In People With Advanced Solid Tumors That Have A Genetic Mutation.
- Investigator: Davendra Sohal
- Posted Date: Feb 10, 2025
- Type of Study: Drug
Randomized Phase II Trial Of Postoperative Adjuvant Capecitabine And Temozolomide Versus Observation In High-Risk Pancreatic Neuroendocrine Tumors
- Investigator: Davendra Sohal
- Posted Date: Apr 26, 2024
- Type of Study: Drug
A Study Of The Efficacy And Safety Of Adjuvant Autogene Cevumeran Plus Atezolizumab And Mfolfirinox Versus Mfolfirinox Alone In Participants With Resected Pancreatic Ductal Adenocarcinoma (Imcode003)
- Investigator: Davendra Sohal
- Posted Date: Apr 25, 2024
- Type of Study: Drug
A Randomized, Double-Blinded, Placebo-Controlled Phase II Study Of Adjuvant Everolimus Following The Resection Of Metastatic Pancreatic Neuroendocrine
- Investigator: Shimul Shah
- Posted Date: May 15, 2019
- Type of Study: Drug
Gemcitabine/Abraxane Chemotherapy And Dose Escalated Radiotherapy For Locally Advanced, Unresectable Pancreatic Cancer
- Investigator: Olugbenga Olowokure
- Posted Date: May 15, 2019
- Type of Study: Drug
A Phase III Trial Evaluating Both Erlotinib And Chemoradiation As Adjuvant Treatment For Patients With Resected Head Of Pancreas Adenocarcinoma
- Investigator: Kevin Redmond
- Posted Date: May 15, 2019
- Type of Study: Drug